20 results on '"Lipoproteins--Metabolism"'
Search Results
2. The association of blood pressure with estimated urinary sodium, potassium excretion and their ratio in hypertensive, normotensive, and hypotensive Chinese adults
- Author
-
Li, Ying, Yin, Lu, Peng, Yaguang, Liu, Xiaoyun, Cao, Xia, Wang, Yaqin, Yang, Pingting, Li, Xiaohui, and Chen, Zhiheng
- Published
- 2020
3. Biochemistry of Lipids, Lipoproteins and Membranes
- Author
-
Neale Ridgway, Roger McLeod, Neale Ridgway, and Roger McLeod
- Subjects
- Membranes (Biology)--Metabolism, Lipoproteins--Metabolism, Lipids--Metabolism
- Abstract
Biochemistry of Lipids, Lipoproteins and Membranes, Seventh Edition serves as a comprehensive, general reference book for scientists and students studying lipids, lipoproteins and membranes. Here, across 19 chapters, leaders in the field summarize fundamental concepts, recent research developments, data analysis, and implications for human disease and intervention. Topics discussed include lipid biology in both prokaryotes and eukaryotes, fatty acid synthesis, desaturation and elongation, and pathways leading to synthesis of complex phospholipids, sphingolipids and their structural variants. Chapters also examine how bioactive lipids are involved in cell signaling, with an emphasis on disease implications and pathological consequences. As the field advances, each chapter in this new edition has been fully revised to address emerging topics, with all-new coverage of lipid droplets and their role as regulatory organelles for energy homeostasis, as well as their relationship to obesity, liver disease and diabetes. Evolving research in fatty acid handling and storage in eukaryotes is also discussed in-depth, with new sections addressing fatty acid uptake, activation and lipolysis. - Fully revised to cover new and emerging topics - Provides an important bridge between broad-based biochemistry research and application - Presents key concepts that are supported by figures and models to improve understanding - Includes references from current literature in each chapter to facilitate in-depth study
- Published
- 2021
4. Biochemistry of Lipids, Lipoproteins and Membranes
- Author
-
Neale Ridgway, Roger McLeod, Neale Ridgway, and Roger McLeod
- Subjects
- Membrane lipids--Metabolism, Cellular signal transduction, Lipids--Metabolism, Lipoproteins--Metabolism
- Abstract
Biochemistry of Lipids: Lipoproteins and Membranes, Volume Six, contains concise chapters that cover a wide spectrum of topics in the field of lipid biochemistry and cell biology. It provides an important bridge between broad-based biochemistry textbooks and more technical research publications, offering cohesive, foundational information. It is a valuable tool for advanced graduate students and researchers who are interested in exploring lipid biology in more detail, and includes overviews of lipid biology in both prokaryotes and eukaryotes, while also providing fundamental background on the subsequent descriptions of fatty acid synthesis, desaturation and elongation, and the pathways that lead the synthesis of complex phospholipids, sphingolipids, and their structural variants. Also covered are sections on how bioactive lipids are involved in cell signaling with an emphasis on disease implications and pathological consequences. - Serves as a general reference book for scientists studying lipids, lipoproteins and membranes and as an advanced and up-to-date textbook for teachers and students who are familiar with the basic concepts of lipid biochemistry - References from current literature will be included in each chapter to facilitate more in-depth study - Key concepts are supported by figures and models to improve reader understanding - Chapters provide historical perspective and current analysis of each topic
- Published
- 2016
5. The role of nutrition and environmental factors in management of familial hypercholesterolemia
- Author
-
Mirzaee, Sam, Cameron, James D, and Nicholls, Stephen J
- Published
- 2019
6. Dyslipidemias in Kidney Disease
- Author
-
Adrian Covic, Mehmet Kanbay, Edgar V. Lerma, Adrian Covic, Mehmet Kanbay, and Edgar V. Lerma
- Subjects
- Kidneys--Diseases, Lipoproteins--Metabolism
- Abstract
Dyslipidemia in chronic kidney disease is a common clinical problem and growing in prevalence. With the recent publication of clinical practice guidelines on the management of lipid related disorders in patients affected by chronic kidney disease, an up-to-date and comprehensive resource of evidence-based literature is needed. Dyslipidemias in Kidney Disease captures the growing body of information on this subject matter. This book presents the latest clinical evidence and management guidance for patients of various demographics and stages of chronic kidney disease. Written for the nephrologist community, as well as cardiologists and general practitioners, this guide will provide practical knowledge and fill a much needed void in the literature.
- Published
- 2014
7. Prevalence of metabolic syndrome in patients with schizophrenia referred to Farabi hospital, Kermanshah, Iran
- Author
-
Shakeri, Jalal, Karimi, Kamyar, Farnia, Vahid, Golshani, Senobar, and Alikhani, Mostafa
- Published
- 2016
8. Drugs, Lipid Metabolism, and Atherosclerosis
- Author
-
David Kritchevsky and David Kritchevsky
- Subjects
- Arteriosclerosis--Chemotherapy--Congresses, Lipids--Metabolism--Congresses, Antilipemic agents--Congresses, Lipoproteins--Metabolism, Metabolism--Drug effects, Lipids--Metabolism, Arteriosclerosis--Drug therapy, Arteriosclerosis--Metabolism
- Abstract
This volume comprises the proceedings of the sixth International Symposium on Drugs Affecting Lipid Meta bolism. Since the first of these symposia in 1960 these triennial meetings have been devoted to the exploration of new ideas, new data and new concepts related to lipid metabolism and atherosclerosis. The sixth Meeting was particularly stimulating in this regard. The concept of the'protective'action of HDL was thoroughly explored within the framework of its molecular biology with data on its epidemiological as well as its in vitro mechan ism(s) of action being discussed. The action of drugs on arterial and HDL metabolism was also discussed as were newer aspects of platelet aggregation, especially as related to prostaglandins. New ground was also broken in discussions of lipid mobilization and mechan isms of hypocholesteremia. We are indebted to the many organizations who con tributed generously to the support of this meeting. Among the sponsors, the assistance of the Lorenzini Foundation was especially helpful. As in all meetings of this type, the hard work of the local organizing committee was instrumental in its success. We are grateful to Mrs. Caroline Hyatt and Mr. Ralph Hollerorth for their invaluable help in the secretariat. We are also deeply indebted to Miss Jane T. Kolimaga for her expert assistance in the preparation of this volume. David Kritchevsky Rodolfo Paoletti William L. Holmes vii Contents LIPOPROTEINS AND DRUGS Lipoprotein Metabolism - New Insights from Cell Biology............................ 3 D. Steinberg Lipoprotein Metabolism in Man....................
- Published
- 2012
9. Clinical Lipidology: A Companion to Braunwald's Heart Disease E-Book
- Author
-
Christie M. Ballantyne and Christie M. Ballantyne
- Subjects
- Lipids--Metabolism, Lipoproteins--Metabolism, Heart--Diseases, Lipids, Lipoproteins
- Abstract
Dr. Ballantyne—one of the foremost lipid experts in the world and recruited by Dr. Braunwald's Heart Disease editorial team—together with a stellar cast of contributors provides all of the scientific and clinical information you need to effectively manage every aspect of dyslipidemia. From basic science to pathogenesis of atherothrombotic disease to risk assessment and the latest therapy options, this new title in the Braunwald's Heart Disease family offers unparalleled coverage and expert guidance on lipidology in a straightforward, accessible, and user-friendly style. • Features the expertise of one of the foremost experts in the field, ensuring you get authoritative guidance with the most definitive knowledge available. • Contains extensive clinically relevant information covering risk assessment, therapy, special patient populations, and experimental therapies, including targeting HDL to help you effectively manage any challenges you face. • Uses treatment algorithms for easy access to key content. • Presents current practice guidelines that assist in the decision-making process.
- Published
- 2009
10. Biochemistry of Lipids, Lipoproteins and Membranes
- Author
-
Neale Ridgway, Roger McLeod, Neale Ridgway, and Roger McLeod
- Subjects
- Membranes (Biology)--Metabolism, Cellular signal transduction, Lipids--Metabolism, Lipoproteins--Metabolism, Lipid membranes
- Abstract
Research on the biochemistry and molecular biology of lipids and lipoproteins has experienced remarkable growth in the past 20 years, particularly with the realization that many different classes of lipids play fundamental roles in diseases such as heart disease, obesity, diabetes, cancer and neurodegenerative disorders. The 5th edition of this book has been written with two major objectives. The first objective is to provide students and teachers with an advanced up-to-date textbook covering the major areas of current interest in the lipid field. The chapters are written for students and researchers familiar with the general concepts of lipid metabolism but who wish to expand their knowledge in this area. The second objective is to provide a text for scientists who are about to enter the field of lipids, lipoproteins and membranes and who wish to learn more about this area of research. All of the chapters have been extensively updated since the 4th edition appeared in 2002. - Represents a bridge between the superficial coverage of the lipid field found in basic biochemistry text books and the highly specialized material contained in scientific review articles and monographs - Allows scientists to become familiar with recent developments related to their own research interests, and will help clinical researchers and medical students keep abreast of developments in basic science that are important for subsequent clinical advances - Serves as a general reference book for scientists studying lipids, lipoproteins and membranes and as an advanced and up-to-date textbook for teachers and students who are familiar with the basic concepts of lipid biochemistry
- Published
- 2008
11. CETP (Cholesteryl Ester Transfer Protein) Inhibition With Anacetrapib Decreases Production of Lipoprotein(a) in Mildly Hypercholesterolemic Subjects
- Author
-
Patricia Jumes, Yang Liu, Thomas P. Roddy, Rajasekhar Ramakrishnan, Wahida Karmally, Gissette Reyes-Soffer, David E. Gutstein, Haihong Zhou, Stephen Holleran, John A. Wagner, Santica M. Marcovina, Amy O. Johnson-Levonas, John S. Millar, Daniel J. Rader, Brian K. Hubbard, Stephen F. Previs, Tiffany Thomas, and Henry N. Ginsberg
- Subjects
0301 basic medicine ,Male ,Time Factors ,Apolipoprotein B ,Atorvastatin ,030204 cardiovascular system & hematology ,Severity of Illness Index ,chemistry.chemical_compound ,0302 clinical medicine ,Interquartile range ,Anacetrapib ,Tandem Mass Spectrometry ,cysteine ,lipoprotein metabolism ,Blood lipoproteins ,biology ,Chemistry ,Anticholesteremic Agents ,Lipoprotein(a) ,Middle Aged ,inhibitor ,Treatment Outcome ,ComputingMethodologies_DOCUMENTANDTEXTPROCESSING ,Medicine ,lipids (amino acids, peptides, and proteins) ,Female ,Hypercholesteremia--Treatment ,Cardiology and Cardiovascular Medicine ,medicine.drug ,ezetimibe ,Adult ,medicine.medical_specialty ,Hypercholesterolemia ,stable isotopes ,Down-Regulation ,Lipoproteins--Metabolism ,Placebo ,03 medical and health sciences ,Double-Blind Method ,Internal medicine ,Cholesterylester transfer protein ,CETP ,medicine ,Humans ,Oxazolidinones ,Aged ,lipoprotein (a) ,Pennsylvania ,Cholesterol Ester Transfer Proteins ,030104 developmental biology ,Endocrinology ,biology.protein ,anacetrapib ,New York City ,Lipoprotein A ,kringle ,Biomarkers ,Lipoprotein ,Clinical and Population Studies ,Chromatography, Liquid - Abstract
Supplemental Digital Content is available in the text., Objective— Lp(a) [lipoprotein (a)] is composed of apoB (apolipoprotein B) and apo(a) [apolipoprotein (a)] and is an independent risk factor for cardiovascular disease and aortic stenosis. In clinical trials, anacetrapib, a CETP (cholesteryl ester transfer protein) inhibitor, causes significant reductions in plasma Lp(a) levels. We conducted an exploratory study to examine the mechanism for Lp(a) lowering by anacetrapib. Approach and Results— We enrolled 39 participants in a fixed-sequence, double-blind study of the effects of anacetrapib on the metabolism of apoB and high-density lipoproteins. Twenty-nine patients were randomized to atorvastatin 20 mg/d, plus placebo for 4 weeks, and then atorvastatin plus anacetrapib (100 mg/d) for 8 weeks. The other 10 subjects were randomized to double placebo for 4 weeks followed by placebo plus anacetrapib for 8 weeks. We examined the mechanisms of Lp(a) lowering in a subset of 12 subjects having both Lp(a) levels >20 nmol/L and more than a 15% reduction in Lp(a) by the end of anacetrapib treatment. We performed stable isotope kinetic studies using 2H3-leucine at the end of each treatment to measure apo(a) fractional catabolic rate and production rate. Median baseline Lp(a) levels were 21.5 nmol/L (interquartile range, 9.9–108.1 nmol/L) in the complete cohort (39 subjects) and 52.9 nmol/L (interquartile range, 38.4–121.3 nmol/L) in the subset selected for kinetic studies. Anacetrapib treatment lowered Lp(a) by 34.1% (P≤0.001) and 39.6% in the complete and subset cohort, respectively. The decreases in Lp(a) levels were because of a 41% reduction in the apo(a) production rate, with no effects on apo(a) fractional catabolic rate. Conclusions— Anacetrapib reduces Lp(a) levels by decreasing its production. Clinical Trial Registration— URL: http://www.clinicaltrials.gov. Unique identifier: NCT00990808.
- Published
- 2017
12. Effects of phytochemicals and sterol oxidation products on lipoprotein metabolism in hamsters.
- Author
-
Liang, Yintong., Chinese University of Hong Kong Graduate School. Division of Life Sciences., Liang, Yintong., and Chinese University of Hong Kong Graduate School. Division of Life Sciences.
- Abstract
高膽固醇血症是產生動脈粥樣硬化的危險因素,本研究旨在探討甾醇的氧化產物和植物化學物質在餵食高膽固醇食金黃地鼠模型中對脂蛋白代謝的影響及其相關機制。, 本研究包含四個部分。食物中同時含有植物甾醇及其氧化產物。第一部分旨在研究β-穀甾醇(Si)、甾醇(St)、β-穀甾醇氧化產物(SiOP)和豆甾醇氧化產物(StOP)對金黃地鼠血脂的影響。本研究顯示,Si和St組能有效降低血總膽固醇(TC)、非高密度脂蛋白膽固醇(non-HDL-C)和甘油三酯(TAG)的水平,而SiOP和StOP則失去此能力。RT-PCR分析表明,Si和St而非SiOP和StOP,能下調腸道醯基輔酶A:膽固醇醯基轉移酶2(ACAT2)和微粒體甘油三酯轉移蛋白(MTP)的mRNA表達。Si和St而非SiOP和StOP能有效防止動脈粥樣硬,Si和St的動脈弓舒張能力強於對照組和SiOP、StOP組。, 辣椒鹼是辣椒中的活性成分。本研究第二部分表明,辣椒鹼能降低TC,NON-HDL-C,TAG,而不影響高密度脂蛋白膽固醇。餵養辣椒鹼能增加糞便中總酸性固醇的排泄,此作用有可能是通過上調膽固醇7α-羥化酶(CYP7A1)和下調肝X受體α(LXRα)的基因表達來實驗。辣椒鹼可通過抑制COX-2基因表達來改善內皮依賴性收縮。, 藍莓含有豐富的抗炎抗氧化劑,例如花青素。本研究第三部分表明,食物中添加0.5和1.0藍莓花青素能導致TC呈劑量效益地降低6-12%,其中還伴隨22-29的中性固醇和41-74%的膽汁酸排泄的增加。RT-PCR分析表明食物中添加的藍莓花青素能下調腸道Niemann-Pick C1 Like 1 (NPC1L1),ACAT2,MTP, 腺苷三磷酸結合盒轉運體G8(ABCG8)和肝臟3-羥基-3-甲基戊二醯輔酶A還原酶(HMG-CoA Reductase)的基因表達。, 芝麻素是芝麻種子中含有抗氧化活性的木脂素類化合物。本研究第四部分表明,在食物中添加芝麻素可有效調控TC和non-HDL-C,同時不影響TAG,並導致非高密度脂蛋白膽固醇與高密度脂蛋白膽固醇比例的下降。這有可能與膽汁酸排泄增加、CYP7A1基因的上調,LXR的下調有關。, 綜上所述,本研究證實了植物甾醇、辣椒鹼、藍莓花青素和芝麻素降低血膽固醇的能力。與此同時,本研究還表明植物甾醇被氧化後將失去其降低膽固醇的能力。, Hypercholesterolemia is a major risk factor in the development of atherosclerosis. Functional foods that can lower or regulate cholesterol concentration are of interest to both public and scientific communities. The present study was to investigate the effects of phytosterols, phytosterol oxidation products (POPs), capsaicinoids, blueberry anthocyanins and sesamin on plasma cholesterol concentration using hamsters as a model., The whole project consisted of four parts. Human diets contain both phytosterols and POPs. Part I was to examine the effect of β-sitosterol (Si), stigmasterol (St), β-sitosterol oxidation products (SiOP) and stigmasterol oxidation products (StOP) on plasma cholesterol concentration. Results showed both Si and St could reduce while SiOP and StOP lost the capacity of lowering plasma total cholesterol (TC), non-high density lipoprotein cholesterol (non-HDL-C) and triacylglycerols (TAG). Real-Time PCR analysis demonstrated Si and St but not SiOP and StOP down-regulated mRNA levels of intestinal acyl CoA: cholesterol acyltransferase 2 (ACAT2) and microsomal triglyceride protein (MTP). In addition, aortas from hamsters given diets containing Si and St relaxed better than those from the control and their corresponding SiOP- and StOP-treated hamsters, suggesting that Si and St not SiOP and StOP were beneficial in improving lipoprotein profile and aortic function., Capsaicinoids refer to a group of pungent compounds that are the active components found in chili peppers. Part II was to investigate the cholesterol-lowering activity of capsaicinoids and the associated molecular mechanisms. Results demonstrated that capsaicinoids reduced plasma TC, non-HDL-C and TAG with high-density lipoprotein cholesterol (HDL-C) being unaffected. This was accompanied by an increase in the fecal excretion of total acidic sterols, possibly mediated by up-regulation of cholesterol 7α-hydroxylase (CYP7A1) and down-regulation of liver X receptor alpha (LXRα). Capsaicinoids could also improve the endothelium-dependent relaxations and reduce the endothelium-dependent contractions by inhibiting the gene expression of COX-2., Blueberries are rich in anthocyanins. Results from Part III experiments demonstrated that dietary supplementation with 0.5 and 1.0 % blueberry anthocyanins for 6 weeks decreased plasma TC concentration by 6-12% in a dose-dependent manner. This was accompanied by increasing the excretion of fecal neutral and acidic sterols by 2229% and 4174%, respectively. Real-time PCR analyses demonstrated that incorporation of blueberry anthocyanins into diet down-regulated the genes of intestinal Niemann-Pick C1-like 1 (NPC1L1), ACAT2, MTP, ABCG 8 and hepatic 3-hydroxy-3-methylglutaryl CoA (HMG-CoA) reductase., Sesamin is a major lignan in sesame seed and is known to exhibit antioxidative activity. Part IV was to investigate the mechanism by which sesamin decreased plasma cholesterol concentration. Results clearly demonstrated supplementation of sesamin into diets could favorably reduce serum TC and non-HDL-C with TAG being unaffected. In addition, dietary supplementation of 0.2 or 0.5% of sesamin could cause a significant decrease in the ratio of non-HDL-C to HDL-C. This was accompanied by a marked increase in bile acid excretion and up-regulation of CYP7A1 and down-regulation of LXRα., In conclusion, phytosterols, capsaicinoids, blueberry anthocyanins and sesamin were beneficial in improving lipoprotein profile in hamsters fed a high-cholesterol diet. However, phytosterols lose the cholesterol-lowering capacity when they are oxidized., Detailed summary in vernacular field only., Liang, Yintong., Thesis (Ph.D.)--Chinese University of Hong Kong, 2012., Includes bibliographical references (leaves 112-123)., s also in Chinese., Chapter Chapter 1 --- General Introduction, Chapter 1.1 --- Cardiovascular diseases --- p.1, Chapter 1.2 --- Cholesterol --- p.2, Chapter 1.3 --- Lipoproteins --- p.4, Chapter 1.4 --- Cholesterol homeostasis --- p.6, Chapter 1.4.1 --- HMG-CoA reductase --- p.7, Chapter 1.4.2 --- LDL receptor --- p.9, Chapter 1.4.3 --- Intestine ACAT2 --- p.10, Chapter 1.4.4 --- NPC1L1 --- p.11, Chapter 1.4.5 --- CYP7A1 and LXRα --- p.12, Chapter 1.4.6 --- SREBP2 --- p.14, Chapter 1.4.7 --- ABCG5 and ABCG8 --- p.15, Chapter 1.5 --- Phytochemicals --- p.16, Chapter 1.5.1 --- Phytosterols --- p.16, Chapter 1.5.2 --- Capsaicinoids --- p.17, Chapter 1.5.3 --- Blueberry anthocyanins --- p.19, Chapter 1.5.4 --- Sesamin --- p.20, Chapter 1.6 --- Animal model --- p.22, Chapter Chapter 2 --- Effect of Phytosterols and their Oxidation Products on Lipoprotein Profiles and Vascular Function, Chapter 2.1 --- Introduction --- p.23, Chapter 2.2 --- Objective --- p.24, Chapter 2.3 --- Materials and methods --- p.24, Chapter 2.3.1 --- Preparation of sitosterol oxidation products (SiOP) and stigmasterol oxidation products (StOP), Chapter 2.3.2 --- Diets --- p.25, Chapter 2.3.3 --- Hamsters --- p.25, Chapter 2.3.4 --- Analysis of individual SiOP and StOP in serum and liver --- p.26, Chapter 2.3.5 --- Analysis of plasma lipoproteins --- p.28, Chapter 2.3.6 --- Measurement of atherosclerotic plaque --- p.28, Chapter 2.3.7 --- Analysis of cholesterol in the liver and aorta --- p.28, Chapter 2.3.8 --- Determination of fecal neutral and acidic sterols --- p.29, Chapter 2.3.9 --- Real-time PCR analysis of mRNA of liver SREBP2, LDL receptor, HMG-CoA reductase, CYP7A1, LXRα, and small intestine NPC1L1, ABCG5, ABCG8, ACAT2, MTP. --- p.29, Chapter 2.3.10 --- Western blotting analysis of hepatic SREBP2, LDL receptor, HMG-CoA reductase, LXRα and CYP7A1 --- p.32, Chapter 2.3.11 --- Vascular reactivity --- p.32, Chapter 2.4 --- Results --- p.34, Chapter 2.4.1 --- Composition of SiOP and StOP --- p.34, Chapter 2.4.2 --- Food intake, body and organ weights --- p.34, Chapter 2.4.3 --- Plasma TC, HDL, non-HDL ,TAG, Non-HDL-C/HDL-C --- p.34, Chapter 2.4.4 --- Aortic cholesterol and atherosclerotic plaque --- p.35, Chapter 2.4.5 --- Liver cholesterol, SiOP and StOP --- p.35, Chapter 2.4.6 --- Fecal neutral, acidic sterols and cholesterol balance --- p.35, Chapter 2.4.7 --- Immunoblot and mRNA analysis --- p.36, Chapter 2.4.8 --- Vascular reactivity --- p.36, Chapter 2.4.9 --- Role of COX in endothelium-dependent contractions --- p.37, Chapter 2.5 --- Discussion --- p.50, Chapter Chapter 3 --- Cholesterol-Lowering Activity of Capsaicinoids Is Mediated by Increasing Sterol Excretion in Hamsters Fed a High Cholesterol Diet, Chapter 3.1 --- Introduction --- p.54, Chapter 3.2 --- Objective --- p.55, Chapter 3.3 --- Materials and methods --- p.55, Chapter 3.3.1 --- Diets --- p.55, Chapter 3.3.2 --- Hamsters --- p.57, Chapter 3.3.3 --- Analysis of plasma lipoproteins --- p.57, Chapter 3.3.4 --- Measurement of atherosclerotic plaque --- p.57, Chapter 3.3.5 --- Analysis of cholesterol in the liver and aorta --- p.57, Chapter 3.3.6 --- Determination of fecal neutral and acidic sterols --- p.57, Chapter 3.3.7 --- Real-time PCR analysis of mRNA of liver SREBP2, LDL receptor, HMG-CoA reductase, CYP7A1, LXRα, and small intestine NPC1L1, ABCG5, ABCG8, ACAT2, MTP --- p.57, Chapter 3.3.8 --- Western blotting analysis of hepatic SREBP2, LDL receptor, HMG-CoA reductase, LXRα and CYP7A1 --- p.58, Chapter 3.3.9 --- Vascular reactivity --- p.58, Chapter 3.4 --- Results --- p.59, Chapter 3.4.1 --- Food intake, body and organ weights --- p.59, Chapter 3.4.2 --- Plasma TC, HDL, non-HDL,TAG, Non-HDL-C/HDL-C --- p.59, Chapter 3.4.3 --- Aortic cholesterol and atherosclerotic plaque --- p.59, Chapter 3.4.4 --- Fecal neutral, acidic sterols and cholesterol balance --- p.59, Chapter 3.4.5 --- Immunoblot and mRNA analysis --- p.60, Chapter 3.4.6 --- Vascular reactivity --- p.60, Chapter 3.4.7 --- Role of COX in endothelium-dependent contractions --- p.61, Chapter 3.5 --- Discussion --- p.74, Chapter Chapter 4 --- Effect of Blueberry Anthocyanins on Lipoprotein Profiles in Hamsters Fed a Cholesterol Diet, Chapter 4.1 --- Introduction --- p.77, Chapter 4.2 --- Objective --- p.78, Chapter 4.3 --- Materials and methods --- p.78, Chapter 4.3.1 --- HPLC analysis of blueberry anthocyanins --- p.78, Chapter 4.3.2 --- Diet --- p.79, Chapter 4.3.3 --- Hamsters --- p.80, Chapter 4.3.4 --- Analysis of plasma lipoproteins --- p.80, Chapter 4.3.5 --- Analysis of cholesterol in the liver --- p.80, Chapter 4.3.6 --- Determination of fecal neutral and acidic sterols --- p.81, Chapter 4.3.7 --- Real-time PCR analysis of mRNA of liver SREBP2, LDL Receptor, HMG-CoA Reductase, CYP7A1, LXRα, and small intestine NPC1L1, ABCG5, ABCG8, ACAT2, MTP --- p.81, Chapter 4.3.8 --- Western blotting analysis of hepatic SREBP2, LDL Receptor, HMG-CoA reductase, LXRα and CYP7A1 --- p.81, Chapter 4.4 --- Results --- p.82, Chapter 4.4.1 --- Food intake, body, and organ weights --- p.82, Chapter 4.4.2 --- Plasma TC, HDL-C, non-HDL-C, and TAG --- p.82, Chapter 4.4.3 --- Liver cholesterol concentration --- p.82, Chapter 4.4.4 --- Fecal total sterols and apparent sterol retention --- p.82, Chapter 4.4.5 --- Immunoblot and mRNA analysis --- p.83, Chapter 4.5 --- Discussion --- p.92, Chapter Chapter 5 --- Effect of Sesamin on Lipoprotein Profiles in Hamsters Fed a high Cholesterol Diet, Chapter 5.1 --- Introduction --- p.95, Chapter 5.2 --- Objective --- p.95, Chapter 5.3 --- Materials and methods --- p.96, Chapter 5.3.1 --- Diets --- p.96, Chapter 5.3.2 --- Hamsters --- p.96, Chapter 5.3.3 --- Methods --- p.97, Chapter 5.4 --- Results --- p.98, Chapter 5.4.1 --- Food intake, body and organ weights --- p.98, Chapter 5.4.2 --- Plasma TC, HDL-C, non-HDL-C ,TAG, Non-HDL-C/HDL-C --- p.98, Chapter 5.4.3 --- Liver cholesterol --- p.98, Chapter 5.4.4 --- Fecal neutral, acidic sterols and cholesterol balance --- p.98, Chapter 5.4.5 --- Immunoblot and mRNA analysis --- p.99, Chapter 5.5 --- Discussion --- p.109, References --- p.112, http://library.cuhk.edu.hk/record=b5549462, Use of this resource is governed by the terms and conditions of the Creative Commons “Attribution-NonCommercial-NoDerivatives 4.0 International” License (http://creativecommons.org/licenses/by-nc-nd/4.0/)
- Published
- 2012
13. Effects of tea seed oil and onion on lipoprotein metabolism in hamsters.
- Author
-
Guan, Lei., Chinese University of Hong Kong Graduate School. Division of Life Sciences., Guan, Lei., and Chinese University of Hong Kong Graduate School. Division of Life Sciences.
- Abstract
Cardiovascular disease (CVD) is a major health problem in developed countries and, with increasing prevalence in developing countries and Eastern Europe. Due to the increased incidence with advancing age, there is a need to develop primary preventive interventions to prolong the period of healthy life. Diet has a substantial influence on health and aging. The composition of the human diet plays an important role in the management of lipid and lipoprotein. In this respect, we have focused on the effects of two kinds of functional foods, tea seed oil and dietary onion on their hypocholesterolemic activities and underlying mechanisms in the present study., Clearly, there are many claims on health benefits of Alliums , however, most, with the exception of garlic, have not received any rigorous or even gentle scientific investigation. Thus, the present study was carried out to explore hypocholesterolemic effects of onion supplementation. After fed for 2 weeks of the high fat high cholesterol diet, thirty-six 8-week male hamsters were divided into four groups. Control group was continued fed with high fat high cholesterol diet, while the other two experimental groups were fed control diet plus 1% (1OP) and 5% (5OP) onion powder for 8 weeks. It was found that feeding high dose of onion powder diet significantly prevented the increase in serum TC, Non-HDL-C and the ratio of non-HDL-C/HDL respectively in hamsters fed a 0.1% cholesterol diet. In contrast, the ratio of HDL/TC in high dose group was significantly increased than that in the control. Low onion dose group tended to have the similar effects as high dose group but, statistically, no difference was observed between the control and low dose groups. Besides, both doses of onion powder diets could significantly countered the increase in serum TG levels. High dose of onion supplementation tended to increase output of fecal neutral and acidic sterols, resulting in reduction of cholesterol retained and absorption. High dose of onion powder diet could significantly up- regulate SREBP-2, LXRbeta, and CYP7A1 protein expressions. The hypocholesterolemic activities of onion might due to the richness in alkyl and alkenyl sulfoxide compounds, anthocyanin, quercetin and cycloalliin, all of which have therapeutic effects., In conclusion, diet plays an important role in reducing the risk of CVD. This has led to the search for specific foods and food components that may help to improve the serum lipoprotein profile. In present study, tea seed oil and onion was proved to help favorably modify the plasma lipoprotein profile, serving as health supplementation. However, their potential mechanisms were not fully studied and need to be further explored., Interest in tea seed oil (named tea oil) as a cooking oil is increasing. However, its effect on blood cholesterol is not known. This study was therefore conducted to compare the hypocholesterolemic activity of tea oil with grape seed, canola and corn oils. Fifty 8-week-old male hamsters were first fed a high fat diet (5% lard), and supplemented with 0.1% cholesterol for 2 weeks and then divided into five groups. Control group was continuously fed high fat high cholesterol diet, while the experimental groups were fed high fat, high cholesterol diet plus 10% tea oil, grape seed oil, canola oil and corn oil for 12 weeks. Results showed that plasma total cholesterol (TC), non-HDL-cholesterol (non-HDL-C) and triacylglycerols (TG) in hamsters fed a 0.1% cholesterol diet containing tea, grape, canola or corn oil was significantly reduced compared with those in lard-fed group. Tea oil decreased only non-HDL-C and had no or little effect on HDL-C concentration, while grape oil reduced both. Besides, tea oil-fed hamsters excreted less neutral but greater acidic sterols compared with other three oils. Unlike grape oil, tea oil up-regulated sterol regulatory element binding protein (SREBP-2) and LDL receptor. Differences between tea oil and the tested vegetable oils could be attributable partially to >80% oleic acid in tea oil., Guan, Lei., Adviser: Chung Hau Yin., Source: Dissertation Abstracts International, Volume: 72-04, Section: B, page: ., Thesis (Ph.D.)--Chinese University of Hong Kong, 2010., Includes bibliographical references (leaves 98-125)., Electronic reproduction. Hong Kong : Chinese University of Hong Kong, [2012] System requirements: Adobe Acrobat Reader. Available via World Wide Web., Electronic reproduction. Ann Arbor, MI : ProQuest Information and Learning Company, [200-] System requirements: Adobe Acrobat Reader. Available via World Wide Web., also in Chinese., isbn: 9781124497778, Use of this resource is governed by the terms and conditions of the Creative Commons “Attribution-NonCommercial-NoDerivatives 4.0 International” License (http://creativecommons.org/licenses/by-nc-nd/4.0/)
- Published
- 2010
14. Effect of proanthocyanidins and consumption frequency of sterols and fatty acids on lipoprotein metabolism in hamsters.
- Author
-
Jiao, Rui., Chinese University of Hong Kong Graduate School. Division of Life Sciences., Jiao, Rui., and Chinese University of Hong Kong Graduate School. Division of Life Sciences.
- Abstract
Grape seed proanthocyanidins (GSP) as a cholesterol-lowering nutraceutical has been investigated in both humans and animals, however, little is known of how it interacts with the genes and proteins involved in lipoprotein metabolism in vivo. So the first objective of the present study was to investigate the effect of GSP supplementation on blood cholesterol level and gene expression of cholesterol-regulating enzymes in Golden Syrian hamsters maintained on a 0.1% cholesterol diet., Hypercholesterolemia is one of the major proven risk factors for atherosclerosis. Decreasing blood total cholesterol (TC) and low-density lipoprotein cholesterol (LDL-C) levels with cholesterol-lowering nutraceuticals and dietary intake modification could slow or reverse the progression of cardiovascular disease., In conclusion, the present study confirmed that hypocholesterolemic activity of GSP was most likely mediated by enhancement of bile acid excretion and up-regulation of CYP7A1. The present study also demonstrated that frequent cholesterol and myristic acid intake is associated with elevation of plasma TC level, while beta-sitosterol intake frequency had no effect on plasma cholesterol for a given amount., In the beta-sitosterol consumption frequency study, hamsters fed the basal diet with a gavage-administration of 3 mg cholesterol 3 times (control), or a gavage-administration of 3 mg beta-sitosterol with 3 mg cholesterol 3 times per day (high beta-sitosterol intake frequency), or a gavage-administration of 9 mg beta-sitosterol with 3 mg cholesterol for one time and 3 mg cholesterol for the other two times (low beta-sitosterol intake frequency). The results demonstrated that for a given dose of beta-sitosterol, the administration frequency had no or little effect on plasma lipoprotein profiles. The present study also found that cholesterol-lowering activity of beta-sitosterol was mediated by its inhibition on the intestinal cholesterol absorption with up-regulation of NPC1L1, ATP binding cassette transporters G5 and G8 (ABCG5/8) and MTP., In the cholesterol consumption frequency study, hamsters were given daily 9 mg of cholesterol either in diet (high cholesterol intake frequency) or a gavage-administration of 3 times 3 mg (regular cholesterol intake frequency) and 1 time 9 mg (low cholesterol intake frequency). The results demonstrated that there was an increasing trend in concentrations of plasma TC, Non-HDL-C, TC/HDL-C ratio and TG in association with the cholesterol intake frequency. It is the first time to demonstrate that the increasing cholesterol intake frequency increased the apparent cholesterol absorption. Elevation of plasma TC and cholesterol absorption is most likely mediated by up-regulation of intestinal Niemann-Pick C1-like 1 (NPC1L1), acyl coenzyme A: cholesterol acyltransferase 2 (ACAT2), and microsomal triacylglycerol transport protein (MTP) gene expression., In the myristic acid consumption frequency study, hamsters were given daily 210 mg of myristic acid either in diet (high myristic acid intake frequency) or a gavage-administration of 3 times 70 mg (regular myristic acid intake frequency) and 1 time 210 mg (low myristic acid intake frequency). The results showed that the increasing consumption frequency elevated plasma TC, Non-HDL-C and HDL-C levels. Elevation of plasma TC and HDL-C is most likely mediated by up-regulation of NPC1L1 and down-regulation of scavenger receptor BI (SR-BI) gene expression via enhancement of dietary myristic acid absorption., The results affirmed supplementation of 0.5% or 1.0% GSP could decrease plasma TC, non-high density lipoprotein cholesterol (Non-HDL-C) and triglyceride (TG) levels. In addition, dietary GSP was able to increase the excretion of bile acids by 3--4 folds, this was partially mediated by up-regulation of Cholesterol 7 alpha-hydroxylase (CYP7A1) in both transcriptional and translational levels. It was concluded that the hypocholesterolemic activity of GSP was most likely mediated by enhancement of bile acid excretion and up-regulation of CYP7A1., The second objective of the present study was to investigate the effect of cholesterol, myristic acid and beta-sitosterol consumption frequency on plasma lipoprotein profiles in hamsters. Numerous studies reported that dietary cholesterol and saturated fatty acids elevated plasma TC level, whereas dietary phytosterols in moderate and high doses favorably reduced plasma TC and LDL levels. However, it is still unknown whether consumption frequency of sterols and fatty acids could affect plasma cholesterol level and lipid profiles., Jiao, Rui., Adviser: Chen Zhen Yu., Source: Dissertation Abstracts International, Volume: 73-02, Section: B, page: ., Thesis (Ph.D.)--Chinese University of Hong Kong, 2010., Includes bibliographical references (leaves 123-150)., Electronic reproduction. Hong Kong : Chinese University of Hong Kong, [2012] System requirements: Adobe Acrobat Reader. Available via World Wide Web., Electronic reproduction. [Ann Arbor, MI] : ProQuest Information and Learning, [201-] System requirements: Adobe Acrobat Reader. Available via World Wide Web., also in Chinese., isbn: 9781267003713, Use of this resource is governed by the terms and conditions of the Creative Commons “Attribution-NonCommercial-NoDerivatives 4.0 International” License (http://creativecommons.org/licenses/by-nc-nd/4.0/)
- Published
- 2010
15. High density lipoprotein free cholesterol saturation studies /
- Author
-
Jenny, Richard William
- Subjects
- Health Sciences, Lipoproteins--Metabolism, Cholestrol metabolism
- Published
- 1981
16. Mechanism and regulation of lipid transfer protein
- Author
-
Ko, Kerry Woon Sing.
- Subjects
- Lipids--Metabolism, Lipoproteins--Metabolism
- Published
- 1996
17. The effects of ascorbic acid and pectin on the lipid status of high cholesterol-fed mice
- Author
-
De Assis, Sandra Regina Petriz.
- Subjects
- Cholesterol--Metabolism, Anticholesteremic agents, Lipoproteins--Metabolism
- Published
- 1989
18. Effects of PCSK9 Inhibition With Alirocumab on Lipoprotein Metabolism in Healthy Humans
- Author
-
Soffer, Gissette, Pavlyha, Marianna, Ngai, Colleen I., Thomas, Tiffany, Holleran, Stephen F., Ramakrishnan, Rajasekhar, Karmally, Wahida, Nandakumar, Renu, Fontanez, Nelson, Obunike, Joseph, Marcovina, Santica M., Lichtenstein, Alice H., Matthan, Nirupa R., Matta, James, Maroccia, Magali, Becue, Frederic, Poitiers, Franck, Swanson, Brian, Cowan, Lisa, Sasiela, William J., Surks, Howard K., and Ginsberg, Henry N.
- Subjects
Medicine ,lipids (amino acids, peptides, and proteins) ,Monoclonal antibodies ,Lipoproteins--Metabolism ,Lipoprotein A ,Proprotein convertases ,3. Good health - Abstract
BACKGROUND: Alirocumab, a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 (PCSK9), lowers plasma low-density lipoprotein (LDL) cholesterol and apolipoprotein B100 (apoB). Although studies in mice and cells have identified increased hepatic LDL receptors as the basis for LDL lowering by PCSK9 inhibitors, there have been no human studies characterizing the effects of PCSK9 inhibitors on lipoprotein metabolism. In particular, it is not known whether inhibition of PCSK9 has any effects on very low-density lipoprotein or intermediate-density lipoprotein (IDL) metabolism. Inhibition of PCSK9 also results in reductions of plasma lipoprotein (a) levels. The regulation of plasma Lp(a) levels, including the role of LDL receptors in the clearance of Lp(a), is poorly defined, and no mechanistic studies of the Lp(a) lowering by alirocumab in humans have been published to date. METHODS: Eighteen (10 F, 8 mol/L) participants completed a placebo-controlled, 2-period study. They received 2 doses of placebo, 2 weeks apart, followed by 5 doses of 150 mg of alirocumab, 2 weeks apart. At the end of each period, fractional clearance rates (FCRs) and production rates (PRs) of apoB and apo(a) were determined. In 10 participants, postprandial triglycerides and apoB48 levels were measured. RESULTS: Alirocumab reduced ultracentrifugally isolated LDL-C by 55.1%, LDL-apoB by 56.3%, and plasma Lp(a) by 18.7%. The fall in LDL-apoB was caused by an 80.4% increase in LDL-apoB FCR and a 23.9% reduction in LDL-apoB PR. The latter was due to a 46.1% increase in IDL-apoB FCR coupled with a 27.2% decrease in conversion of IDL to LDL. The FCR of apo(a) tended to increase (24.6%) without any change in apo(a) PR. Alirocumab had no effects on FCRs or PRs of very low-density lipoproteins-apoB and very low-density lipoproteins triglycerides or on postprandial plasma triglycerides or apoB48 concentrations. CONCLUSIONS: Alirocumab decreased LDL-C and LDL-apoB by increasing IDL- and LDL-apoB FCRs and decreasing LDL-apoB PR. These results are consistent with increases in LDL receptors available to clear IDL and LDL from blood during PCSK9 inhibition. The increase in apo(a) FCR during alirocumab treatment suggests that increased LDL receptors may also play a role in the reduction of plasma Lp(a). CLINICAL TRIAL REGISTRATION: URL: http://www.clinicaltrials.gov. Unique identifier: NCT01959971.
19. Molecular Genetics of Coronary Artery Disease : Candidate Genes and Processes in Atherosclerosis
- Author
-
A. J. Lusis, J. I. Rotter, R. S. Sparkes, A. J. Lusis, J. I. Rotter, and R. S. Sparkes
- Subjects
- Atherosclerosis--Genetic aspects, Atherosclerosis--Pathophysiology, Coronary heart disease--Etiology, Coronary heart disease--Risk factors, Blood lipoproteins--Metabolism, Atherosclerosis--genetics, Coronary Arteriosclerosis--genetics, Lipoproteins--metabolism
- Abstract
'Detailed reviews of structural, biochemical, genetic, and interactive disease factors determining the development of atherosclerosis. Well-documented. A survey for basic and clinical investigators in genetics, cardiology, and pathology who are concerned with these topics.'Annals of Internal Medicine
- Published
- 1992
20. Biochemistry of Lipids, Lipoproteins and Membranes
- Author
-
Dennis E. Vance, J.E. Vance, Dennis E. Vance, and J.E. Vance
- Subjects
- Biochemistry, Cell membranes, Lipids--Metabolism, Lipoproteins--Metabolism, Membrane lipids--Metabolism
- Abstract
This is the third edition of this advanced textbook, written with two major objectives in mind. One is to provide an advanced textbook covering the major areas in the fields of lipid, lipoprotein, and membrane biochemistry, and molecular biology. The second objective is to provide a clear summary of these research areas for scientists presently working in these fields.The volume provides the basis for an advanced course for students in the biochemistry of lipids, lipoproteins and membranes. The book will satisfy the need for a general reference and review book for scientists studying lipids, proteins and membranes. Excellent up-to-date reviews are available on the various topics covered. A current, readable, and critical summary of these areas of research, it will allow scientists to become familiar with recent developments related to their own research interests, and will help clinical researchers and medical students keep abreast of developments in basic science that are important for subsequent clinical advances.
- Published
- 1996
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.